{"id":2098,"date":"2022-04-08T00:34:48","date_gmt":"2022-04-08T00:34:48","guid":{"rendered":"https:\/\/smasteer.wpengine.com\/oor-die-studie\/"},"modified":"2022-07-19T21:21:12","modified_gmt":"2022-07-19T21:21:12","slug":"oor-die-studie","status":"publish","type":"page","link":"https:\/\/thesteerstudy.com\/af\/","title":{"rendered":"Oor Die Studie"},"content":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;5&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;325473&#8243; row_name=&#8221;what-is&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_custom_heading text_size=&#8221;h1&#8243; text_height=&#8221;fontheight-181378&#8243; uncode_shortcode_id=&#8221;269975&#8243; subheading=&#8221;Die doel van die STEER Studie is om te verstaan of die ondersoekende geen-terapie OAV101 veilig is en kan help om spierfunksie te verbeter in kinders van 2 jaar oud en jonger as 18 jaar met Tipe 2 SMA.&#8221;]Wat is die doel van die STEER Studie?[\/vc_custom_heading][vc_button button_color=&#8221;color-jevc&#8221; size=&#8221;btn-lg&#8221; radius=&#8221;btn-round&#8221; border_animation=&#8221;btn-ripple-out&#8221; outline=&#8221;yes&#8221; border_width=&#8221;2&#8243; button_color_type=&#8221;uncode-palette&#8221; uncode_shortcode_id=&#8221;156485&#8243; link=&#8221;url:%23neem%20deel|&#8221;]Wie kan aansluit?[\/vc_button][vc_single_image media=&#8221;76&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;128483&#8243;][\/vc_column][vc_column width=&#8221;1\/2&#8243;][vc_custom_heading text_size=&#8221;h1&#8243; text_height=&#8221;fontheight-181378&#8243; uncode_shortcode_id=&#8221;163679&#8243; subheading=&#8221;OAV101 is \u2019n geen-terapie wat ontwerp is om \u2019n nuwe funksionele kopie van die SMN1-geen na die motoriese neurone te stuur. Die doel van die nuwe SMN1-geen is om genoeg SMN prote\u00efen te maak en verdere verlies van motoriese neurone te voorkom.&#8221;]Wat is OAV101?[\/vc_custom_heading][vc_single_image media=&#8221;200&#8243; media_width_percent=&#8221;90&#8243; alignment=&#8221;center&#8221; uncode_shortcode_id=&#8221;194517&#8243;][\/vc_column][\/vc_row][vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;5&#8243; top_padding=&#8221;3&#8243; bottom_padding=&#8221;3&#8243; back_color=&#8221;color-914595&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;410730&#8243; back_color_type=&#8221;uncode-palette&#8221; row_name=&#8221;participate&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_single_image media=&#8221;79&#8243; media_width_percent=&#8221;100&#8243; uncode_shortcode_id=&#8221;107057&#8243;][\/vc_column][vc_column column_width_percent=&#8221;90&#8243; position_horizontal=&#8221;left&#8221; position_vertical=&#8221;middle&#8221; gutter_size=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; shift_x=&#8221;0&#8243; shift_y=&#8221;0&#8243; shift_y_down=&#8221;0&#8243; z_index=&#8221;0&#8243; medium_width=&#8221;0&#8243; mobile_width=&#8221;0&#8243; width=&#8221;1\/2&#8243; uncode_shortcode_id=&#8221;136271&#8243;][vc_custom_heading text_size=&#8221;h1&#8243; text_height=&#8221;fontheight-181378&#8243; uncode_shortcode_id=&#8221;125477&#8243; subheading=&#8221;Die studie is vir kinders van 2 jaar oud en jonger as 18 jaar met Tipe 2 SMA wat:&#8221;]Wie kan in hierdie studie deelneem?[\/vc_custom_heading][uncode_list uncode_shortcode_id=&#8221;237932&#8243;]<\/p>\n<ul>\n<li>\u2022 In staat is om onafhanklik te sit, maar nog nooit onafhanklik kon loop nie.<\/li>\n<li>\u2022 Simptome van SMA begin toon het op 6 maande of ouer.<\/li>\n<li>\u2022 Nog nie enige behandelings ontvang het wat SMN verhoog nie.<\/li>\n<\/ul>\n<p>[\/uncode_list][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row unlock_row_content=&#8221;yes&#8221; row_height_percent=&#8221;0&#8243; override_padding=&#8221;yes&#8221; h_padding=&#8221;5&#8243; top_padding=&#8221;4&#8243; bottom_padding=&#8221;3&#8243; overlay_alpha=&#8221;50&#8243; gutter_size=&#8221;4&#8243; column_width_percent=&#8221;100&#8243; shift_y=&#8221;0&#8243; z_index=&#8221;0&#8243; uncode_shortcode_id=&#8221;325473&#8243; row_name=&#8221;what-is&#8221;][vc_column width=&#8221;1\/2&#8243;][vc_custom_heading text_size=&#8221;h1&#8243; text_height=&#8221;fontheight-181378&#8243; uncode_shortcode_id=&#8221;269975&#8243; subheading=&#8221;Die doel [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":1492,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"inline_featured_image":false,"footnotes":""},"class_list":["post-2098","page","type-page","status-publish","has-post-thumbnail","hentry"],"_links":{"self":[{"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/pages\/2098","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/comments?post=2098"}],"version-history":[{"count":0,"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/pages\/2098\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/media\/1492"}],"wp:attachment":[{"href":"https:\/\/thesteerstudy.com\/af\/wp-json\/wp\/v2\/media?parent=2098"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}